DE3016289A1
(de)
*
|
1980-04-28 |
1981-10-29 |
Henkel KGaA, 4000 Düsseldorf |
Verfahren zur herstellung von omega -amino-1-hydroxyalkyliden-1,1-bis-phosphonsaeuren
|
DE3151038A1
(de)
*
|
1981-12-23 |
1983-07-28 |
Henkel KGaA, 4000 Düsseldorf |
Verfahren zur herstellung von 3-amino-1-hydroxypropan-1,1-diphosphonsaeure
|
US4446052A
(en)
*
|
1982-05-17 |
1984-05-01 |
The Procter & Gamble Company |
Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
|
DE3334211A1
(de)
*
|
1983-09-22 |
1985-04-04 |
Henkel KGaA, 4000 Düsseldorf |
Dihydroxyalkandiphosphonsaeuren
|
DE3425812A1
(de)
*
|
1984-07-13 |
1986-01-16 |
Deutsches Krebsforschungszentrum, 6900 Heidelberg |
Neue 1-hydroxy-1,1-diphosphonsaeureverbindungen, verfahren zu ihrer herstellung und pharmakologische zubereitungen, insbesondere zur behandlung von knochentumoren
|
US4639338A
(en)
*
|
1984-08-06 |
1987-01-27 |
Ciba-Geigy Corporation |
Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
|
DE3434667A1
(de)
*
|
1984-09-21 |
1986-04-03 |
Henkel KGaA, 4000 Düsseldorf |
4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
|
DE3623397A1
(de)
*
|
1986-07-11 |
1988-01-14 |
Boehringer Mannheim Gmbh |
Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
|
DE3640708C2
(de)
*
|
1986-11-28 |
1995-05-18 |
Schering Ag |
Verbesserte metallhaltige Pharmazeutika
|
DE3700772A1
(de)
*
|
1987-01-13 |
1988-07-21 |
Inst Khim Kinetiki I Gorenija |
Verfahren zur herstellung von i-funktionellsubstituierten alkyliden-i,i-diphosphonsaeuren und deren gemischen
|
US5154843A
(en)
*
|
1989-02-08 |
1992-10-13 |
The Lubrizol Corporation |
Hydroxyalkane phosphonic acids and derivatives thereof and lubricants containing the same
|
US4922007A
(en)
*
|
1989-06-09 |
1990-05-01 |
Merck & Co., Inc. |
Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
|
US5139786A
(en)
*
|
1989-07-07 |
1992-08-18 |
Ciba-Geigy Corporation |
Topical formulations
|
MX21452A
(es)
*
|
1989-07-07 |
1994-01-31 |
Ciba Geigy Ag |
Preparaciones farmaceuticas que se administran en forma topica.
|
US5019651A
(en)
*
|
1990-06-20 |
1991-05-28 |
Merck & Co., Inc. |
Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
|
US5349026A
(en)
*
|
1992-11-20 |
1994-09-20 |
Rohm And Haas Company |
Reactive coalescents
|
US20010007863A1
(en)
*
|
1998-06-18 |
2001-07-12 |
Merck & Co., Inc. |
Wet granulation formulation for bisphosphonic acids
|
KR100192215B1
(ko)
*
|
1996-09-03 |
1999-06-15 |
강재헌 |
3-아미노-1-히드록시프로판-1,1-디포스폰산의 제조방법
|
US6160165A
(en)
|
1998-12-10 |
2000-12-12 |
Aesgen, Inc. |
Method for preparation of disodium pamidronate
|
US6794536B1
(en)
|
1998-12-10 |
2004-09-21 |
Aesqen, Inc. |
Method for preparation of disodium pamidronate
|
AR021347A1
(es)
*
|
1999-10-20 |
2002-07-17 |
Cipla Ltd |
Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
|
US6677320B2
(en)
|
2000-01-20 |
2004-01-13 |
Hoffmann-La Roches Inc. |
Parenteral bisphosphonate composition with improved local tolerance
|
US6562974B2
(en)
|
2000-02-01 |
2003-05-13 |
The Procter & Gamble Company |
Process for making geminal bisphosphonates
|
US6410520B2
(en)
|
2000-02-01 |
2002-06-25 |
The Procter & Gamble Company |
Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
|
US20060269602A1
(en)
*
|
2001-04-13 |
2006-11-30 |
Dasch James R |
Method of modifying the release profile of sustained release compositions
|
US6558702B2
(en)
*
|
2001-04-13 |
2003-05-06 |
Alkermes Controlled Therapeutics, Inc. |
Method of modifying the release profile of sustained release compositions
|
CA2372450A1
(en)
*
|
2001-05-10 |
2001-09-19 |
Pharmaceutical Partners Of Canada Inc. |
Liquid injectable formulation of disodium pamidronate
|
TWI349553B
(en)
*
|
2001-12-21 |
2011-10-01 |
Procter & Gamble |
Kit and use of bisphosphonate for treating high bone turnover
|
ITMI20020908A1
(it)
*
|
2002-04-29 |
2003-10-29 |
Chemi Spa |
Processo di preparazione di sodio alendronato
|
PL399493A1
(pl)
*
|
2002-05-10 |
2012-11-05 |
F. Hoffmann-La Roche Ag |
Kwasy bisfosfonowe do leczenia i profilaktyki osteoporozy
|
JP4485117B2
(ja)
*
|
2002-06-27 |
2010-06-16 |
日東電工株式会社 |
保護剥離用フィルム
|
US20040138180A1
(en)
*
|
2002-10-03 |
2004-07-15 |
Barr Laboratories, Inc. |
Bisphosphonate composition and process for the preparation thereof
|
DK1596870T4
(da)
*
|
2002-12-20 |
2011-06-14 |
Hoffmann La Roche |
Højdosis-ibandronatformulering
|
US20040206932A1
(en)
*
|
2002-12-30 |
2004-10-21 |
Abuelyaman Ahmed S. |
Compositions including polymerizable bisphosphonic acids and methods
|
US7449499B2
(en)
*
|
2003-08-12 |
2008-11-11 |
3M Innovative Properties Company |
Self-etching dental compositions and methods
|
WO2005090370A1
(en)
*
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
JP5214242B2
(ja)
*
|
2004-07-08 |
2013-06-19 |
スリーエム イノベイティブ プロパティズ カンパニー |
歯科用の方法、組成物、および酸感受性色素を含むキット
|
KR101260525B1
(ko)
*
|
2004-08-11 |
2013-05-06 |
쓰리엠 도이칠란드 게엠베하 |
다수의 산성 화합물을 포함하는 자체-접착성 조성물
|
EP1832293A4
(en)
*
|
2004-12-10 |
2009-01-07 |
Tmrc Co Ltd |
MEANS FOR THE TREATMENT OF CANCER METASTAS AND CANNESMAS TREATMENT
|
US20070003608A1
(en)
*
|
2005-04-08 |
2007-01-04 |
Almond Merrick R |
Compounds, compositions and methods for the treatment of viral infections and other medical disorders
|
EP1868628B1
(en)
|
2005-04-08 |
2014-06-11 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
EP1984430A2
(de)
|
2006-02-03 |
2008-10-29 |
Universität Stuttgart - Institut für Chemische Verfahrenstechnik |
Phosphonsäure-haltige blends und phosphonsäure-haltige polymere
|
WO2008076739A2
(en)
*
|
2006-12-13 |
2008-06-26 |
3M Innovative Properties Company |
Methods of using a dental composition having an acidic component and a photobleachable dye
|
ES2572631T3
(es)
*
|
2008-01-25 |
2016-06-01 |
Chimerix, Inc. |
Métodos de tratamiento de infecciones virales
|
WO2011011519A1
(en)
|
2009-07-21 |
2011-01-27 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
CA2770282A1
(en)
|
2009-08-03 |
2011-02-10 |
Chimerix, Inc. |
Composition and methods of treating viral infections and viral induced tumors
|
HUE032860T2
(en)
|
2010-02-12 |
2017-11-28 |
Chimerix Inc |
A method for treating a virus infection
|
WO2011139709A2
(en)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
PL407922A1
(pl)
|
2014-04-16 |
2015-10-26 |
Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością |
Nowe bisfosfoniany i ich zastosowanie
|